Velpatasvir
Back to searchMolecule Structure
Scientific Name
Velpatasvir
Description of the Drug
Velpatasvir is a NS5A inhibitor used to treat chronic hepatitis C infections in patients without cirrhosis or with compensated cirrhosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11613
http://www.drugbank.ca/drugs/DB11613
Brand Name(s)
Not Available
Company Owner(s)
Gilead Sciences Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Nonstructural protein 5A | SINGLE PROTEIN | INHIBITOR | CHEMBL3307224 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL19236068 | SCHEMBL8756902 |
| PharmGKB | PA166163415 | |
| DrugBank | DB11613 | |
| PubChem | 67683363 | |
| Nikkaji | J3.631.686A | |
| DrugCentral | 5154 | |
| ChemicalBook | CB62743053 | |
| Guide to Pharmacology | 11269 | |
| rxnorm | VELPATASVIR | |
| ChEBI | 133009 | |
| ZINC | ZINC000203686879 |
